The clinical information you need, at your fingertips.

Medical News for You

JAMA

Will AI alone best physician-AI collaboration?

Autonomous AI already matches or beats physicians on five cognitive tasks and adding physician review may reduce accuracy rather than improve it. . .

JAMA Netw Open

35m

H-1B limits could hit primary care residencies hardest

Non-US international medical graduates account for about a quarter of first-year US primary care trainees. . .

JAMA Netw Open

One antipsychotic may carry lower hyponatremia risk

Real-world data suggest aripiprazole may be associated with less hyponatremia than olanzapine among patients starting second-generation antipsychotics. . .

Comput Biol Med

Wearables, AI closely track arterial BP in ICU

Cuffless monitoring is edging from consumer wellness toward clinical-grade waveform data. . .

Company news

Enhertu outperforms standard first-line therapy in HER2-mutant NSCLC

Phase 3 DESTINY-Lung04 met its primary endpoint, positioning trastuzumab deruxtecan as a potential targeted alternative to chemoimmunotherapy at metastatic diagnosis. . .

JAMA Netw Open

Popular album releases tied to spike in traffic deaths

A national analysis of fatal crashes found that blockbuster album release days were associated with a 15% increase in traffic deaths as music streaming volumes surged. . .

Gastro Hep Adv

Daily sugary drinks tied to gastric cancer risk

Sugar-sweetened beverage intake did not track with H. pylori infection, and adds to the short list of dietary exposures linked to this cancer. . .

FDA

FDA clears first CELMoD therapy for multiple myeloma

Accelerated approval of iberdomide-based ZDd brings a first-in-class treatment approach to patients whose disease has returned after initial therapy. . .

JAMA Oncol

Metabolic syndrome in nearly 4 in 10 men after prostate cancer therapy

Metabolic abnormalities appeared early after starting androgen deprivation therapy plus an androgen receptor pathway inhibitor, supporting close cardiometabolic monitoring. . .